Introduction
Search "medical device manufacturing license USA" and you'll expect a single form, one agency, one certificate. That's not how it works.
US market entry runs through several separate requirements:
- FDA device classification
- A premarket pathway (or exemption)
- Establishment registration and device listing
- A working quality system
- State facility or distribution permits, where required
This matters whether you're a foreign manufacturer shipping your first unit into the US, a startup building a Class II device, an established company adding a new product line, or a contract manufacturer producing for someone else's brand.
Your compliance path depends on how the device is classified, its intended use, what happens at your facility, and how you plan to distribute it.
This article maps the full picture: the federal and state authorities involved, what actually counts as a "license," how classification drives your premarket route, how to prepare operationally, and what stays on your plate after you're cleared to sell.
Key Takeaways
- FDA establishment registration and device listing identify your firm and products; they do not authorize commercial sale alone.
- Class I, II, and III devices use different premarket paths: exemption, 510(k), De Novo, or PMA.
- Documented quality, production, validation, labeling, and complaint systems must exist before you ship.
- State licensing may apply separately based on device type, business model, and where you make or distribute.
Key Federal and State Authorities Involved in Medical Device Manufacturing
Three types of regulators make different decisions about your device, and conflating them is one of the most common early mistakes.
FDA, through its Center for Devices and Radiological Health (CDRH), is the primary authority. CDRH handles:
- Device classification and premarket submission review
- Establishment registration and device listing
- Inspections and quality system enforcement
- Compliance actions when something goes wrong
U.S. Customs and Border Protection (CBP) plays a narrower, separate role. When devices, components, or finished products physically cross the border, CBP processes the entry filing, but FDA decides whether the product is admissible. A smooth customs clearance is not FDA market authorization, and the two shouldn't be treated as interchangeable checkpoints.
State agencies add a third layer. Depending on where you're located or selling, a state health department, board of pharmacy, or similar agency may require:
- A manufacturing license for the facility itself
- Separate wholesale or distribution registration
- Facility inspections or responsible-person designations
- Periodic renewals independent of your FDA timeline
Because state rules differ and change, treat this as something to research per state rather than assume a single nationwide rule applies. We'll go deeper on specific state examples later in this article.
What Counts as a Medical Device Manufacturing License in the US?
Here's the short version: there is no single federal document called a "medical device manufacturing license." What people mean by that phrase is really a compliance package: establishment registration, device listing, the applicable premarket authorization, a working quality management system, facility controls, and any state licenses your activities trigger.
Your Role Determines Your Obligations
Different business roles trigger different registration and listing duties under 21 CFR Part 807:
| Role | Typical obligation |
|---|---|
| Domestic or foreign finished-device manufacturer | Registers and lists |
| Specification developer | Registers and lists |
| Contract manufacturer (makes to another's spec) | Registers and lists |
| Repackager or relabeler | Registers and lists |
| Initial importer | Registers, but generally doesn't list solely in that role |
| Pure wholesale distributor | Generally neither registers nor lists in that capacity |
Multiple entities can carry obligations for the same device: a specification developer and the contract manufacturer who builds it both have duties, and neither one's registration number is proof the product is cleared.
Registration Is Not Approval
This misconception is widespread. FDA's own guidance confirms that an entry in the registration and listing database does not denote approval, clearance, or authorization of the facility or its devices. Registration just confirms FDA knows you exist and what you're listing.
Device listing itself requires keeping information current: intended use, the listing manufacturer, and establishment details. Lapsed or inaccurate listings can complicate inspections and, in some cases, market access.
Build Your License Stack
Before production or sale, map these elements against each other:
- Legal entity: who is the registered manufacturer on paper?
- Facility: where is production actually happening?
- Device and intended use: what does the labeling claim?
- Premarket status: exempt, 510(k), De Novo, or PMA?
- Quality system: is it built and functioning, not just documented?
- State footprint: which states does this device touch?
One more warning: CE marking, ISO 13485 certification, or approval from another country's regulator does not substitute for US requirements. That evidence can support your broader regulatory file and quality system, but FDA still expects its own classification, premarket pathway, and registration process to be satisfied independently.
How Device Classification and Premarket Pathways Affect Licensing
FDA classifies devices based on intended use, indications, technology, and risk, not on how a product is categorized elsewhere or how it's marketed. A device that's Class I in one country can land differently under FDA rules.
The Three Classes, at a Glance
- Class I: general controls apply (think bandages, manual tongue depressors); many are exempt from 510(k)
- Class II: special controls apply on top of general controls (infusion pumps, powered wheelchairs); most need a 510(k)
- Class III: generally requires premarket approval (implantable pacemakers, certain heart valves)
Not every device in a class follows an identical path. Exemptions have limits, and some older Class III devices carry transitional provisions. Check FDA's product classification database for your specific product code before assuming anything.
Three Premarket Routes
| Pathway | What it requires | FDA 2025 review goal |
|---|---|---|
| 510(k) | Substantial equivalence to a legally marketed predicate, including matching intended use and comparable technology | 95% within 90 FDA days |
| De Novo | For novel, lower-to-moderate-risk devices with no suitable predicate; a successful decision creates a new classification | 70–90% within 150 FDA days |
| PMA | Valid scientific evidence of safety and effectiveness, often including clinical data; generally required for Class III | 90% within 180 FDA days |
Those percentages are performance goals, not guaranteed timelines. FDA's CDRH received 21,780 device submissions and authorized 124 novel devices in 2025. That volume is useful context for scale, but not a promise about how long your specific submission will take. Evidence quality and how FDA questions get answered matter more than the published target.
For software, combination products, sterile devices, implantables, and radiation-emitting equipment, pull current device-specific guidance before locking in a pathway. These categories tend to carry extra wrinkles that generic guidance won't cover.
How to Prepare and Apply for US Medical Device Manufacturing Compliance
Once you know your classification and pathway, the operational work starts.
Start With a Device and Business Profile
Document intended use, indications, user population, components and accessories, software elements, sterility requirements, manufacturing sites, and proposed labeling claims. Decide whether production happens in-house or through a contract manufacturer. That choice affects who registers and who lists.
Get the Facility and Quality System Ready
Your facility needs controls matched to the device's risk level:
- Documented premises, equipment, and environmental controls
- Trained technical staff and supplier controls
- Production procedures, inspection methods, and traceability
Your quality management system needs to align with current FDA requirements and ISO 13485 principles. The amended Part 820, the Quality Management System Regulation (QMSR), incorporates ISO 13485:2016 and became effective February 2, 2026. Confirm current effective dates before you finalize your QMS documentation.
Prepare the Core Records
- Design history or technical documentation
- Risk-management records
- Device master or production records
- Validation protocols and test reports
- Labeling and UDI information, where applicable
- Supplier qualification records
Sequence the Steps
- Confirm premarket status (exemption, 510(k), De Novo, or PMA)
- Complete the required submission or exemption documentation
- Register the establishment
- List the device accurately
- Verify that the legal manufacturer and manufacturing activities match what's on file
Run a Pre-Inspection Readiness Review
Before FDA shows up, review these areas:
- Document control and training records
- CAPA and nonconforming product handling
- Complaint processes and process validation
- Equipment maintenance and internal audits
- Management responsibility
Gaps here are what turn a routine inspection into a 483.
Foreign Manufacturers: The US Agent Isn't Your Importer
Under 21 CFR 807.40, foreign establishments must designate one US Agent in their registration. This contact assists with FDA communications and inspection scheduling.
The US Agent is not the same role as the importer of record, initial importer, distributor, customs broker, or regulatory consultant. FDA is clear that the agent isn't automatically responsible for MDR submissions or 510(k) filings just by holding that title.
Business support runs in parallel with FDA submissions. A foreign manufacturer entering the US typically needs a US entity structure, bookkeeping aligned with US accounting standards, payroll if hiring locally, and federal and state tax compliance.
VJM Global works with foreign companies on that layer: entity setup, accounting, tax compliance, and operational coordination for a US-facing business. FDA submissions, technical testing, and device-specific regulatory decisions stay with qualified regulatory specialists and testing labs.
State Licensing, Facility Requirements, and Market-Access Considerations
FDA clearance doesn't automatically satisfy every state requirement, particularly for prescription devices or anything touching pharmacy-adjacent activities.
State requirements vary widely. A few examples illustrate the range:
- California requires a Medical Device Manufacturing License under its Health and Safety Code, with additional requirements for some ophthalmic device manufacturers, wholesalers, or importers.
- Texas separately licenses manufacturers and distributors, with distributor coverage extending to importers and own-label distributors.
- New Jersey requires registration for businesses distributing medical devices, covering both in-state and out-of-state locations.
- Pennsylvania uses "registration" terminology for businesses that manufacture, distribute, or retail devices in-state.
Research requirements for your actual facilities, products, sales channels, and distribution footprint — not a generic national assumption. Pay special attention to:
- Contract and virtual manufacturers
- Software as a medical device
- Prescription devices
- Temperature-sensitive products
- Multi-state distribution networks
Build a phased compliance map tracking each state's license or exemption status, the responsible owner, renewal dates, inspection requirements, and supporting evidence. State rules shift through legislative and agency updates, so schedule periodic reviews rather than treating the map as a one-time task.
Ongoing Compliance After Manufacturing Authorization
Getting registered, listed, and cleared is only the start. Compliance continues through:
- Production monitoring and quality records
- Supplier oversight and change control
- Complaint handling
- Corrective and preventive action (CAPA)
Post-Market Reporting Has Short Clocks
Medical Device Reporting, corrections and removals, recalls, and adverse-event investigations all carry specific timelines and recipients. Those requirements differ by your role as manufacturer, importer, or user facility.
Verify current thresholds and deadlines directly from FDA before launch. These clocks move fast, and missing one turns a manageable issue into an enforcement problem.
Changes Trigger New Assessments
Changes in any of the following can require a documented regulatory assessment, and sometimes a new submission or notification:
- Intended use or labeling
- Materials or software
- Manufacturing location or sterilization method
- Suppliers or processes
Don't assume minor-seeming changes are automatically exempt.
Common Failure Points
- Treating registration as if it were approval
- Submitting inconsistent manufacturer information across filings
- Starting production before premarket requirements are met
- Relying solely on foreign certifications in place of US requirements
- Failing to document post-market decisions and rationale
Keep a renewal and monitoring calendar covering FDA registrations, state licenses, facility permits, quality audits, staff training, and regulatory updates. This single habit prevents more compliance gaps than any other practice.
Conclusion
US medical device manufacturing compliance is a coordinated system across multiple requirements. It typically covers:
- FDA classification and the correct premarket pathway
- Establishment registration and device listing
- A working quality system and facility readiness
- Accurate labeling, applicable state rules, and post-market surveillance
The right path depends on risk profile, intended use, manufacturing role, facility setup, and distribution model. Generic advice only goes so far.
Verify current FDA and state requirements before you commit to production or a US launch. Bring in qualified regulatory specialists for complex or high-risk devices.
For the business infrastructure that runs alongside that work—entity setup, accounting, and tax compliance—VJM Global supports foreign companies building their US operational base.
Frequently Asked Questions
What is the difference between an FDA 510(k) and a PMA?
A 510(k) shows your device is substantially equivalent to a legally marketed predicate. A PMA requires valid scientific evidence of safety and effectiveness, often including clinical data. Which one applies depends on your device's classification and current FDA requirements.
How are medical devices regulated in the US?
Through FDA classification, the applicable premarket pathway, establishment registration, device listing, quality system requirements, labeling rules, inspections, and post-market reporting. State agencies may add separate obligations on top of these federal requirements.
What are the FDA's new regulations for 2026?
Rules and effective dates change, so verify current requirements directly with FDA before relying on any summary. At minimum, check your quality management system status, registration details, reporting obligations, and any device-specific guidance that applies to you.
Does FDA registration mean a medical device is approved for sale?
No. Establishment registration and device listing confirm FDA has your information on file — they don't equal 510(k) clearance, De Novo classification, PMA approval, or an exemption from other applicable requirements.
Do medical device manufacturers need state licenses in the US?
It depends on the state, device type, facility, and business model. Review each relevant state's health department or equivalent agency separately from your FDA compliance work, since requirements aren't standardized nationally.
